Progress and challenges in implementing the research on ESKAPE pathogens

Infection Control and Hospital Epidemiology

Volumn 31, Issue SUPPL. 1, 2010, Pages

  Rice, Louis B ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CONFERENCE PAPER; ENTEROBACTER; ENTEROCOCCUS FAECIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; RELIABILITY; STAPHYLOCOCCUS AUREUS; TECHNIQUE;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DIFFUSION OF INNOVATION; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; EVIDENCE-BASED MEDICINE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS;

EID: 78449256152     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/655995     Document Type: Conference Paper

References (32)

1. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355(26):2725-2732. (Pubitemid 46021509)
2. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 2008;197(8):1079-1081.
3. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996-1011.
4. European Antimicrobial Resistance Surveillance System (EARSS). EARSS annual report 2007. Bilthoven, the Netherlands: EARSS; 2008. http://www.rivm.nl/earss/Images/EARSS%202007-FINAL-tcm61-55933.pdf. Accessed 1 July 2010.
5. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993;175(1):117-127. (Pubitemid 23016657)
6. Carias LL, Rudin SD, Donskey CJ, Rice LB. Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 1998;180(17):4426-4434.
7. Rice LB, Bellais S, Carias LL, et al. Impact of specific pbp5 mutations on expression of β-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004;48(8):3028-3032.
8. Fuda CC, Fisher JF, Mobashery S. β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci 2005;62(22):2617-2633. (Pubitemid 41721234)
9. Jacoby GA, Medeiros AA. More extended-spectrum ß-lactamases. Antimicrob Agents Chemother 1991;35(9):1697-1704.
10. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174(3):529-536. (Pubitemid 26299686)
11. Pitout JD. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev Anti Infect Ther 2008;6(5):657-669.
12. Rice LB, Carias LL, Hutton RA, Rudin SD, Endimiani A, Bonomo RA. The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008;52(9):3427-3429.
13. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538-582.
14. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 2003;67(4):593-656. (Pubitemid 37549772)
15. Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006;2(1):e7.
16. Whitecar JP Jr, Luna M, Bodey GP. Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci 1970;60(4):216-223.
17. Livermore DM. Interplay of impermeability and chromosomal ß-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992;36(9):2046-2048.
18. Tam VH, Chang KT, Abdelraouf K, et al. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010;54:1160-1164.
19. Jacobs C, Frere J-M, Normark S. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible ß-lactam resistance in gram-negative bacteria. Cell 1997;88(6):823-832. (Pubitemid 27164270)
20. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for β-lactamase induction. EMBO J 1994;13(19):4684-4694. (Pubitemid 24310220)
21. Jacobs C, Joris B, Jamin M, et al. AmpD, essential for both ß-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase. Mol Microbiol 1995;15(3):553-559.
22. Sanders CC, Sanders WE Jr, Goering RV. In vitro antagonism of β-lactam antibiotics by cefoxitin. Antimicrob Agents Chemother 1982;21:968-975.
23. Schmidtke AJ, Hanson ND. Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008;52(11):3922-3927.
24. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10(4):781-791. (Pubitemid 27477734)
25. Rice LB, Carias LL, Rudin S, et al. Role of class A penicillin-binding proteins in the expression of β-lactam resistance in Enterococcus faecium. J Bacteriol 2009;191(11):3649-3656.
26. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009;22(4):664-689.
27. Hernandez-Alles S, Alberti S, Alvarez D, et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 1999;145(3):673-679.
28. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008;322:107-131.
29. Brook I. The role of beta-lactamase-producing-bacteria in mixed infections. BMC Infect Dis 2009;9:202.
30. Yim G, Wang HH, Davies J. Antibiotics as signalling molecules. Philos Trans R Soc Lond B Biol Sci 2007;362(1483):1195-1200.
31. Projan SJ, Shlaes DM. Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect 2004;10(Suppl 4):18-22. (Pubitemid 40946196)
32. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48(1):1-12.